Inventory

3 Months Ended

Mar. 31, 2021

Inventory Disclosure [Abstract]

Inventory

(4) Inventory

The Company capitalizes its purchases of saleable inventory of VASCEPA from suppliers that have been qualified by the U.S. FDA. Inventories as of March 31, 2021 and December 31, 2020 consist of the following:

In thousands	March 31, 2021		December 31, 2020
Raw materials	$	69,463	$	50,657
Work in process		36,094		30,388
Finished goods		125,335		107,819
Total inventory	$	230,892	$	188,864